EX-FILING FEES 3 ex107.htm CALCULATION OF FILING FEE TABLE

 

Exhibit 107

 

Calculation of Filing Fee Table

 

FORM S-1

(Form Type)

 

Qualigen Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  

Security

Type

 

Security

Class Title

 

Fee

Calculation

Rate

  

Amount

Registered

  

Proposed

Maximum

Offering

Price Per

Unit

  

Maximum

Aggregate

Offering

Price (1)

   Fee Rate  

Amount of

Registration

Fee

 
Fees to be paid  Equity  Common Stock (2)   457(o)    -       -   $12,000,00.00    0.00011020   $1,322.40 
Fees to be Paid  Equity  Pre-Funded Warrants   457(g)   -    -    (3)   -    - 
Fees to be Paid  Equity  Common Stock Warrants   457(g)   -    -    (3)   -    - 
Fees to be Paid  Equity  Common Stock issuable upon exercise of Pre-Funded Warrants (2)   457(o)   -    -    (4)   -    - 
Fees to be Paid  Equity  Common Stock issuable upon exercise of Common Stock Warrants (2)   457(o)   -    -   $  12,000,000.00    0.00011020   $1,322.40 
      Total Offering Amount   $24,000,000.00        $2,644.80 
      Total Fees Previously Paid              - 
      Total Fee Offsets              - 
      Net Fee Due             $2,644.80 

 

 

(1) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2) Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
   
(3) Pursuant to Rule 457(g) under the Securities Act, no separate registration fee is required for the warrants.
   
(4) The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $12,000,000.